Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alcohol Drinking | 18 | 2017 | 4013 | 2.600 |
Why?
|
Alcoholic Beverages | 6 | 2016 | 264 | 1.720 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 264 | 1.250 |
Why?
|
Alcohol-Related Disorders | 4 | 2015 | 235 | 1.100 |
Why?
|
Australia | 13 | 2017 | 1289 | 1.000 |
Why?
|
Drug Users | 3 | 2014 | 132 | 0.980 |
Why?
|
Leisure Activities | 4 | 2017 | 306 | 0.970 |
Why?
|
Harm Reduction | 3 | 2015 | 145 | 0.820 |
Why?
|
Splenic Neoplasms | 1 | 2021 | 95 | 0.720 |
Why?
|
Automobile Driving | 2 | 2016 | 438 | 0.700 |
Why?
|
Food Industry | 2 | 2011 | 67 | 0.690 |
Why?
|
Self Efficacy | 2 | 2014 | 630 | 0.690 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 179 | 0.660 |
Why?
|
Cities | 3 | 2017 | 538 | 0.660 |
Why?
|
Risk-Taking | 3 | 2014 | 998 | 0.630 |
Why?
|
Hematopoiesis | 7 | 2023 | 2050 | 0.620 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2023 | 2919 | 0.610 |
Why?
|
Sports | 3 | 2013 | 700 | 0.610 |
Why?
|
Violence | 2 | 2015 | 927 | 0.600 |
Why?
|
Adolescent Behavior | 3 | 2015 | 1175 | 0.580 |
Why?
|
Leukemia | 4 | 2022 | 1520 | 0.560 |
Why?
|
Crime | 2 | 2014 | 202 | 0.520 |
Why?
|
Alcoholic Intoxication | 2 | 2016 | 174 | 0.520 |
Why?
|
Licensure | 1 | 2016 | 128 | 0.500 |
Why?
|
Conflict of Interest | 2 | 2011 | 549 | 0.500 |
Why?
|
Juvenile Delinquency | 1 | 2015 | 116 | 0.490 |
Why?
|
DNA Damage | 2 | 2023 | 2442 | 0.470 |
Why?
|
Marketing | 3 | 2012 | 220 | 0.470 |
Why?
|
Internet | 4 | 2014 | 3078 | 0.460 |
Why?
|
Ascorbic Acid | 1 | 2017 | 655 | 0.460 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1375 | 0.450 |
Why?
|
Aggression | 3 | 2013 | 745 | 0.450 |
Why?
|
Industry | 2 | 2012 | 361 | 0.440 |
Why?
|
Mutation | 12 | 2024 | 29932 | 0.430 |
Why?
|
Substance Abuse Detection | 1 | 2015 | 301 | 0.420 |
Why?
|
Integrin beta3 | 1 | 2013 | 121 | 0.420 |
Why?
|
Food Labeling | 1 | 2015 | 180 | 0.420 |
Why?
|
Public Relations | 1 | 2011 | 22 | 0.390 |
Why?
|
Substance-Related Disorders | 5 | 2017 | 4371 | 0.390 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.390 |
Why?
|
Awareness | 1 | 2015 | 646 | 0.370 |
Why?
|
Neoplastic Stem Cells | 5 | 2018 | 1347 | 0.370 |
Why?
|
Wine | 1 | 2011 | 167 | 0.360 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 3224 | 0.360 |
Why?
|
Beer | 1 | 2010 | 134 | 0.340 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1628 | 0.330 |
Why?
|
Personal Satisfaction | 1 | 2014 | 643 | 0.330 |
Why?
|
Dioxygenases | 2 | 2022 | 335 | 0.330 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21025 | 0.320 |
Why?
|
Health Status | 2 | 2014 | 4081 | 0.320 |
Why?
|
Health Education | 1 | 2015 | 1049 | 0.320 |
Why?
|
Social Responsibility | 1 | 2011 | 386 | 0.310 |
Why?
|
Rural Population | 3 | 2014 | 2268 | 0.310 |
Why?
|
Athletes | 2 | 2012 | 1125 | 0.300 |
Why?
|
Universities | 2 | 2012 | 992 | 0.300 |
Why?
|
Financial Management | 1 | 2009 | 161 | 0.290 |
Why?
|
RNA Interference | 3 | 2016 | 2846 | 0.290 |
Why?
|
Data Collection | 3 | 2014 | 3315 | 0.290 |
Why?
|
Groin | 1 | 2007 | 107 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3602 | 0.290 |
Why?
|
Behavior, Addictive | 2 | 2011 | 462 | 0.290 |
Why?
|
Femoral Vein | 1 | 2007 | 153 | 0.280 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2477 | 0.270 |
Why?
|
Humans | 60 | 2024 | 760621 | 0.260 |
Why?
|
Social Behavior | 1 | 2012 | 1131 | 0.260 |
Why?
|
Urban Population | 1 | 2014 | 2022 | 0.260 |
Why?
|
Thalidomide | 2 | 2022 | 884 | 0.250 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1343 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5251 | 0.230 |
Why?
|
Health Surveys | 2 | 2014 | 4063 | 0.230 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 530 | 0.210 |
Why?
|
Peptide Termination Factors | 1 | 2022 | 56 | 0.200 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.200 |
Why?
|
Oncogenes | 2 | 2022 | 1220 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 6 | 2022 | 3387 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6315 | 0.200 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 412 | 0.200 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 305 | 0.180 |
Why?
|
Female | 27 | 2024 | 391270 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.180 |
Why?
|
Polymerization | 1 | 2020 | 157 | 0.170 |
Why?
|
Dipeptides | 1 | 2022 | 409 | 0.170 |
Why?
|
Quality of Life | 2 | 2014 | 13308 | 0.170 |
Why?
|
Young Adult | 12 | 2022 | 58741 | 0.170 |
Why?
|
Hematologic Neoplasms | 3 | 2022 | 1895 | 0.170 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 234 | 0.170 |
Why?
|
Mice | 13 | 2023 | 81208 | 0.160 |
Why?
|
Taxes | 2 | 2011 | 222 | 0.160 |
Why?
|
Adult | 18 | 2024 | 219994 | 0.160 |
Why?
|
Ferritins | 1 | 2022 | 597 | 0.160 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1416 | 0.160 |
Why?
|
Sampling Studies | 2 | 2010 | 613 | 0.160 |
Why?
|
Aminopyridines | 1 | 2022 | 564 | 0.150 |
Why?
|
Serine | 1 | 2022 | 830 | 0.150 |
Why?
|
Cell Cycle | 2 | 2023 | 2934 | 0.150 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2010 | 64 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13262 | 0.150 |
Why?
|
Adolescent | 11 | 2022 | 87810 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 502 | 0.150 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1753 | 0.150 |
Why?
|
Male | 22 | 2022 | 359744 | 0.150 |
Why?
|
Health Policy | 1 | 2010 | 2677 | 0.150 |
Why?
|
Victoria | 2 | 2014 | 64 | 0.140 |
Why?
|
Public Policy | 2 | 2011 | 560 | 0.140 |
Why?
|
Odds Ratio | 2 | 2022 | 9716 | 0.140 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3084 | 0.140 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2023 | 1889 | 0.140 |
Why?
|
Middle Aged | 14 | 2024 | 220352 | 0.130 |
Why?
|
Germ Cells | 1 | 2020 | 635 | 0.130 |
Why?
|
CLOCK Proteins | 1 | 2016 | 86 | 0.130 |
Why?
|
ARNTL Transcription Factors | 1 | 2016 | 94 | 0.130 |
Why?
|
Neoplasms | 2 | 2022 | 22072 | 0.130 |
Why?
|
Gout | 1 | 2022 | 620 | 0.120 |
Why?
|
Self Report | 2 | 2017 | 3711 | 0.120 |
Why?
|
Age Factors | 3 | 2016 | 18416 | 0.120 |
Why?
|
Base Sequence | 2 | 2018 | 12446 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 869 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1056 | 0.120 |
Why?
|
Protein Conformation | 1 | 2022 | 3969 | 0.120 |
Why?
|
Animals | 14 | 2023 | 167963 | 0.120 |
Why?
|
Research Design | 1 | 2010 | 6180 | 0.120 |
Why?
|
Casein Kinase Ialpha | 1 | 2014 | 26 | 0.120 |
Why?
|
Social Control, Formal | 1 | 2014 | 108 | 0.120 |
Why?
|
Health Personnel | 1 | 2007 | 3310 | 0.110 |
Why?
|
Sequence Deletion | 1 | 2018 | 1493 | 0.110 |
Why?
|
Age of Onset | 1 | 2020 | 3301 | 0.110 |
Why?
|
Biomedical Research | 1 | 2009 | 3426 | 0.110 |
Why?
|
Aged | 9 | 2024 | 169152 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 940 | 0.110 |
Why?
|
Markov Chains | 1 | 2016 | 968 | 0.100 |
Why?
|
Signal Transduction | 2 | 2013 | 23376 | 0.100 |
Why?
|
Alcoholism | 2 | 2016 | 1961 | 0.100 |
Why?
|
Databases, Genetic | 1 | 2019 | 1738 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 609 | 0.100 |
Why?
|
Ethics, Business | 1 | 2011 | 8 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2295 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1454 | 0.100 |
Why?
|
Chromatin | 1 | 2023 | 2938 | 0.100 |
Why?
|
Peer Review, Research | 1 | 2014 | 340 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 717 | 0.090 |
Why?
|
Logistic Models | 2 | 2016 | 13314 | 0.090 |
Why?
|
Age Distribution | 1 | 2017 | 2893 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1257 | 0.090 |
Why?
|
Antisocial Personality Disorder | 1 | 2011 | 224 | 0.090 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 301 | 0.090 |
Why?
|
Central Nervous System Depressants | 1 | 2011 | 164 | 0.090 |
Why?
|
Databases, Bibliographic | 1 | 2010 | 130 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2019 | 2566 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2659 | 0.080 |
Why?
|
Mental Recall | 1 | 2015 | 1206 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1634 | 0.080 |
Why?
|
Risk Factors | 4 | 2022 | 74359 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4490 | 0.080 |
Why?
|
Heroin Dependence | 1 | 2009 | 172 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1297 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9276 | 0.080 |
Why?
|
beta Catenin | 1 | 2013 | 1043 | 0.080 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 3442 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3726 | 0.070 |
Why?
|
Employment | 1 | 2014 | 1112 | 0.070 |
Why?
|
Cell Death | 3 | 2022 | 1672 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9585 | 0.070 |
Why?
|
Research Support as Topic | 1 | 2011 | 699 | 0.070 |
Why?
|
Genetic Enhancement | 1 | 2006 | 17 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3420 | 0.070 |
Why?
|
Genomics | 2 | 2019 | 5794 | 0.070 |
Why?
|
Neuraminidase | 1 | 2006 | 200 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5877 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3610 | 0.070 |
Why?
|
Program Evaluation | 1 | 2014 | 2493 | 0.070 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2006 | 173 | 0.060 |
Why?
|
Commerce | 1 | 2011 | 605 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 25942 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2007 | 1385 | 0.060 |
Why?
|
Personal Autonomy | 1 | 2007 | 302 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2013 | 1596 | 0.060 |
Why?
|
Social Environment | 1 | 2010 | 1022 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3276 | 0.060 |
Why?
|
Ethanol | 1 | 2011 | 1323 | 0.060 |
Why?
|
Smoking | 1 | 2022 | 9073 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54303 | 0.060 |
Why?
|
Hedgehog Proteins | 1 | 2009 | 769 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3523 | 0.060 |
Why?
|
Prevalence | 2 | 2024 | 15687 | 0.060 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 22023 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12103 | 0.060 |
Why?
|
Immunotherapy | 1 | 2019 | 4642 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5253 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7806 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 188 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2019 | 14372 | 0.050 |
Why?
|
Sex Factors | 1 | 2016 | 10547 | 0.050 |
Why?
|
Demography | 1 | 2007 | 1650 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 370 | 0.050 |
Why?
|
Choice Behavior | 1 | 2007 | 821 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4775 | 0.050 |
Why?
|
Research | 1 | 2010 | 1974 | 0.050 |
Why?
|
Pilot Projects | 2 | 2022 | 8555 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17624 | 0.040 |
Why?
|
Genes, p53 | 1 | 2022 | 713 | 0.040 |
Why?
|
Brain Stem Neoplasms | 1 | 2022 | 190 | 0.040 |
Why?
|
Solvents | 1 | 2020 | 292 | 0.040 |
Why?
|
Mental Health | 1 | 2014 | 3213 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 368 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 788 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 832 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14495 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 854 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2208 | 0.040 |
Why?
|
Synthetic Biology | 1 | 2020 | 185 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4283 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2018 | 16939 | 0.040 |
Why?
|
Public Health | 1 | 2011 | 2653 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 640 | 0.040 |
Why?
|
Medical Record Linkage | 1 | 2019 | 288 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2007 | 2001 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2315 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2023 | 80372 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 530 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 642 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 998 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2022 | 2221 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2019 | 863 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3448 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
Health Behavior | 1 | 2007 | 2622 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15840 | 0.030 |
Why?
|
Ubiquitination | 1 | 2020 | 1008 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1792 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1736 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40165 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2039 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1313 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 71 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3529 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2007 | 3865 | 0.030 |
Why?
|
Lovastatin | 1 | 2013 | 116 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7818 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 404 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 3986 | 0.030 |
Why?
|
Tyrphostins | 1 | 2012 | 63 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2022 | 4264 | 0.030 |
Why?
|
New South Wales | 1 | 2011 | 70 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 29658 | 0.020 |
Why?
|
Blast Crisis | 1 | 2012 | 101 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 21392 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2012 | 246 | 0.020 |
Why?
|
Serpins | 1 | 2012 | 247 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13630 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5434 | 0.020 |
Why?
|
Financial Support | 1 | 2011 | 116 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3758 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5397 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18137 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 646 | 0.020 |
Why?
|
Child | 2 | 2022 | 79806 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 734 | 0.020 |
Why?
|
Survival Rate | 1 | 2022 | 12808 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 12922 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1513 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2009 | 221 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5791 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9994 | 0.020 |
Why?
|
Cricetulus | 1 | 2006 | 815 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2571 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 12960 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1229 | 0.010 |
Why?
|
CHO Cells | 1 | 2006 | 1389 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9411 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2427 | 0.010 |
Why?
|
Protein Engineering | 1 | 2006 | 541 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5797 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1245 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11712 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39261 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36060 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42063 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58995 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3334 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5643 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8035 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10446 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 65017 | 0.000 |
Why?
|